ORICIRO
LIVE

Serial Number

79274176

Owner

OriCiro Genomics, Inc.

Attorney

Sandra Epp Ryan

Filing Date

Jul 23, 2019

Add to watchlist:

No watchlists yet
View on USPTO

ORICIRO Trademark

Serial Number: 79274176 • Registration: 6197550

ORICIRO is a trademark filed by OriCiro Genomics, Inc. on July 23, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

OriCiro Genomics, Inc.

South Clinical Research Bldg.

Entity Type: 03

Trademark Details

Filing Date

July 23, 2019

Registration Date

November 17, 2020

Published for Opposition

September 1, 2020

Goods & Services

Chemical reagents for medical purposes; diagnostic reagents for medical purposes; reagents for use in medical genetic testing; reagents, for medical purposes; diagnostic preparations for medical purposes; pharmaceutical preparations, for the treatment of diseases caused by genetic disorder; reagent paper for medical purposes

Genetic specimen samplers, other than for medical use, namely, testing sample collection equipment in the nature of wipes and swabs for use in diagnostic testing, not for medical purposes; DNA chips; DNA chip making apparatus being a DNA microarray apparatus; DNA synthesizing apparatus, namely, DNA microarray; DNA analyzing apparatus, namely, laboratory research instruments for DNA analysis; scientific apparatus and instruments and laboratory apparatus for research purposes, namely, polymerase chain reaction thermocyclers used to amplify DNA, for analytical and research purposes; DNA fragmentation apparatus, namely, laboratory apparatus to separate or for breaking DNA strands into pieces; gene testing equipment for research purposes, namely, electrical equipment for the genetic modification of cells for research purposes; analytical apparatus, namely, laboratory apparatus for extracting DNA for use in laboratory; laboratory kits for use with reagents for DNA amplification comprised primarily of laboratory apparatus for extracting DNA and laboratory devices for detecting genetic sequences; laboratory kits for use with reagents for genetic research comprised primarily of laboratory apparatus for extracting DNA and laboratory devices for detecting genetic sequences; laboratory apparatus and instruments in the form of kits comprised primarily of laboratory apparatus for extracting DNA and laboratory devices for detecting genetic sequences; measuring or testing machines and instruments, namely, scientific apparatus and instruments for measuring relative DNA, RNA and protein

Chemical reagents for genetic research, other than for medical or veterinary purposes; chemical reagents, other than for medical or veterinary purposes; reagents for scientific and research use, namely, for DNA amplification; reagents for genetic research purposes, other than for medical or veterinary purposes; reagents for research purposes; reagents for scientific purposes for use in nucleic acid isolation and purification; reagents for scientific purposes; chemicals for use in the manufacture of pharmaceuticals; industrial chemicals; test paper, chemical; reagent paper, other than for medical or veterinary purposes

Custom treatment of materials in the nature of syntheses of DNA; custom treatment of materials in the nature of syntheses of RNA; custom treatment of materials in the nature of syntheses of nucleic acids; custom treatment of materials in the nature of amplification of DNA; custom manufacture of chemicals; processing of chemical reagents; processing of medicinal materials, namely, medicinal plants; custom manufacture, namely, extraction, purification and syntheses of pharmaceuticals; custom manufacture of pharmaceuticals; treatment of biopharmaceutical materials by means of DNA engineering; providing material treatment information

Testing, inspection, research or development services in the fields of genes, namely, research in the fields of genetics, gene therapy, DNA and chemical and biological production methods; consultancy and information services relating to testing, inspection, research or development services in the fields of genes, namely, scientific research consulting in the fields of genetics, gene therapy, DNA and chemical and biological production methods; scientific research in the fields of genetics and genetic engineering; testing, inspection, research or development services in the fields of chemistry, namely, scientific research and development in the fields of chemistry; consultancy and information services relating to testing, inspection, research or development services in the fields of chemistry, namely, chemistry consultation; testing, inspection, research or development services in the fields of pharmaceuticals, namely, testing, inspection, research, or development of pharmaceutical preparations for gene therapy including DNA and RNA-based therapy and vaccines; consultancy and information services relating to testing, inspection, research or development services in the fields of pharmaceuticals, namely, scientific research consulting in the fields of pharmaceuticals; testing, inspection or research on agriculture, livestock breeding or fisheries; testing or research on prevention of pollution; scientific laboratory services

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Nov 17, 2025 REM3
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 20, 2022 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jan 20, 2022 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 20, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 20, 2022 REAP
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 21, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 26, 2021 FICS
FINAL DISPOSITION PROCESSED
Feb 26, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 17, 2021 FICR
NEW REPRESENTATIVE AT IB RECEIVED
Dec 11, 2020 NREP
REGISTERED-PRINCIPAL REGISTER
Nov 17, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 1, 2020 NPUB
PUBLISHED FOR OPPOSITION
Sep 1, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 12, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 24, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 23, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 22, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 22, 2020 TROA
REFUSAL PROCESSED BY IB
Feb 8, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 23, 2020 RFCS
REFUSAL PROCESSED BY MPU
Jan 23, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 24, 2019 RFCR
APPLICATION FILING RECEIPT MAILED
Dec 24, 2019 MAFR
NON-FINAL ACTION WRITTEN
Dec 23, 2019 CNRT
ASSIGNED TO EXAMINER
Dec 20, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 20, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 19, 2019 REPR